<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7518803\results\search\testTrace\results.xml">
  <result pre="long as the COVID-19 resource centre remains active. Abstract The" exact="infection" post="epidemic event of the severe acute respiratory syndrome coronavirus"/>
  <result pre="respiratory symptoms. With the increase in confirmed cases, however, the" exact="infection" post="symptoms turn to be diverse with secondary or first"/>
  <result pre="damage, means that the overall health burden caused by SARS-CoV-2" exact="infection" post="may be under-estimated because COVID-19 patients developed cardiovascular system"/>
  <result pre="combination with recently published medical data of patients having SARS-CoV-2" exact="infection" post="and the latest studies, the manifestations of damage to"/>
  <result pre="system by COVID-19, possible pathogenic mechanisms and advances of the" exact="treatment" post="are proposed in this article. Graphical abstract Highlights â€¢The"/>
  <result pre="target during the treatment. Keywords COVID-19 Myocardial injury Mechanisms and" exact="treatment" post="1 Introduction On February 11, 2020, the Coronaviridae Study"/>
  <result pre="The World Health Organization (WHO) declared that the novel coronavirus" exact="infection" post="was named coronavirus disease 2019 (COVID-19) [1]. By March"/>
  <result pre="SARS-CoV-2â€&quot;related cardiovascular symptoms and potential mechanisms and search for potential" exact="treatment" post="targets and practical treatment strategies to facilitate epidemic prevention"/>
  <result pre="potential mechanisms and search for potential treatment targets and practical" exact="treatment" post="strategies to facilitate epidemic prevention and control. 2 SARS-CoV-2-related"/>
  <result pre="suffer from severe heart failure in the wake of SARS-CoV-2" exact="infection" post="and eventually die of sudden cardiac death [7]. Likewise,"/>
  <result pre="[7]. Likewise, Hu et al. reported a case of coronavirus" exact="infection" post="presenting fulminant myocarditis [13], and Gnecchi et al. reported"/>
  <result pre="have a long-term effect on the heart [17,18]. 2.3 SARS-CoV-2" exact="infection" post="with underlying cardiovascular disease Some SARS-CoV-2 patients have chronic"/>
  <result pre="and these patients are more susceptible to severe conditions after" exact="infection" post="[8]. The Chinese Centers for Disease Control and Prevention"/>
  <result pre="hypertension and cardiac insufficiency. Further analysis showed that the SARS-CoV-2" exact="infection" post="only induced heart failure and systemic multiorgan dysfunction in"/>
  <result pre="3 SARS-CoV-2 possible mechanisms for heart damage 3.1 Direct cardiac" exact="infection" post="by SARS-CoV-2 Some COVID-19 patients have chest pain and"/>
  <result pre="pathological evidence is needed to confirm the direction of cardiomyocyte" exact="infection" post="by SARS-CoV-2. 3.2 Downregulation of ACE2 in cardiac tissues"/>
  <result pre="syndrome patients Patient with renal failure symptoms 1.General and symptomatic" exact="treatment" post="2.Etiological therapy 3.Continuous renal replacement therapy Patient with disease"/>
  <result pre="replacement therapy Patient with disease progressed quickly 1.General and symptomatic" exact="treatment" post="2.Rehabilitee plasma therapy Patient with cytokine storm 1.General and"/>
  <result pre="2.Rehabilitee plasma therapy Patient with cytokine storm 1.General and symptomatic" exact="treatment" post="2.Blood purification: plasma exchange, adsorption, perfusion i.e. Patient with"/>
  <result pre="Patient with the increase of serum IL-6 1.General and symptomatic" exact="treatment" post="2.Immunotherapy: trastuzumab (IL-6 mAb) Patient with excessive inflammatory response,"/>
  <result pre="response, severe respiratory distress and so on 1.General and symptomatic" exact="treatment" post="2.Glucocorticoid 3.Xuebijing injection (a traditional Chinese medicine): intravenous 100â€¯ml/day,"/>
  <result pre="intravenous 100â€¯ml/day, twice a day 4.Microecological preparation prevents secondary bacterial" exact="infection" post="COVID-19 patient complicated with cardiovascular system injury COVID-19 patient"/>
  <result pre="of myocardial injury. 3.4 Other mechanisms Hypoxemia caused by viral" exact="infection" post="is another important mechanism of cardiac damage since it"/>
  <result pre="side effects of antiviral drugs cannot be underestimated during the" exact="treatment" post="of COVID-19. The Diagnosis and Treatment Plan of Coronavirus"/>
  <result pre="stress cardiomyopathy. 4 Treatment of cardiovascular injury associated with SARS-CoV-2" exact="infection" post="4.1 Antiviral therapy The Diagnosis and Treatment Plan of"/>
  <result pre="COVID-19 patients is warranted. In addition, researchers found that early" exact="treatment" post="with the triple antiviral therapy combination of interferon beta-1b"/>
  <result pre="in healthy adults [49]. However, one study found that lopinavir/ritonavir" exact="treatment" post="is no better than standard care in hospitalized adult"/>
  <result pre="COVID-19 [50]. 4.2 ACE2 as a potential target during the" exact="treatment" post="of SARS-CoV-2 infection SARS-CoV-2 mainly invades alveolar epithelial cells"/>
  <result pre="ACE2 as a potential target during the treatment of SARS-CoV-2" exact="infection" post="SARS-CoV-2 mainly invades alveolar epithelial cells via ACE2 and"/>
  <result pre="changing its configuration may be potential approaches. Chloroquine inhibits viral" exact="infection" post="by increasing the pH of the viral inclusion bodies"/>
  <result pre="that ACEIs and ARBs can increase the risk of SARS-CoV-2" exact="infection" post="or cause deterioration of COVID-19 patients [62], so ACEIs"/>
  <result pre="kidneys [65]. 4.3 Treatment of cytokine storms associated with SARS-CoV-2" exact="infection" post="As mentioned previously, SARS-CoV-2 infection could induce overactivation of"/>
  <result pre="cytokine storms associated with SARS-CoV-2 infection As mentioned previously, SARS-CoV-2" exact="infection" post="could induce overactivation of the immune system, resulting in"/>
  <result pre="protecting organ function is a promising approach to treat SARS-CoV-2" exact="infection" post="and reduce mortality. Currently, most targeted drugs for COVID-19"/>
  <result pre="COVID-19 are still being tested in preclinical studies, and symptomatic" exact="treatment" post="remains the primary therapy. It is essential to promptly"/>
  <result pre="cytokine storms: antishock therapy, supportive and symptomatic treatment, proper steroid" exact="treatment" post="at an appropriate dose level, and neutralizing antibodies [66]."/>
  <result pre="may be used to treat cytokine storms associated with SARS-CoV-2" exact="infection" post="[68]. Zhou et al. found that granulocyte-macrophage colony stimulating"/>
  <result pre="methods for treating and preventing COVID-19. 4.4 Treatment of SARS-CoV-2" exact="infection" post="with underlying cardiovascular diseases Current data show that all"/>
  <result pre="and improve cardiac function, and when heart failure occurs, etiological" exact="treatment" post="is the optimal choice. In addition to routine anti-heart"/>
  <result pre="a critical cardiovascular condition occurs in a COVID-19 patient, the" exact="treatment" post="principles include treatment of the viral infection first, followed"/>
  <result pre="condition occurs in a COVID-19 patient, the treatment principles include" exact="treatment" post="of the viral infection first, followed by risk assessment,"/>
  <result pre="COVID-19 patient, the treatment principles include treatment of the viral" exact="infection" post="first, followed by risk assessment, conservative treatment (preferred), and"/>
  <result pre="of the viral infection first, followed by risk assessment, conservative" exact="treatment" post="(preferred), and self-protection. Thrombolysis is preferred for patients with"/>
  <result pre="balance and improve myocardial metabolism, and mental health intervention and" exact="counseling" post="are also essential for effective treatment. 5 Preventive measures"/>
  <result pre="of SARS-CoV-2 in China [76]. Therefore, increasing the identification and" exact="isolation" post="of asymptomatic patients would be important to fully control"/>
  <result pre="This is of vital importance for both the decision of" exact="isolation" post="and the guidance of the duration of antiviral therapy"/>
  <result pre="the prognosis of patients. 6 Conclusion The outbreak of SARS-CoV-2" exact="infection" post="has been defined as a pandemic that is seriously"/>
  <result pre="health care professionals must be knowledgeable about the prevention and" exact="treatment" post="of infectious diseases while paying attention to the underlying"/>
  <result pre="provide a relatively comprehensive summary and some directions for clinical" exact="treatment" post="and new therapeutic targets of COVID-19. Funding This work"/>
  <result pre="syndromePostgrad. Med. J.82200614014416461478 10T.g.o.S.o.X.h.CThe clinical characteristics of SARS and its" exact="treatment" post="and prognosis with attached clinical reports of 220 casesJournal"/>
  <result pre="University of Medical Sciences2420032003361367 11GuanW.NiZ..HuY.LiangW.OuC.HeJ.Clinical characteristics of 2019 novel coronavirus" exact="infection" post="in ChinamedRxiv382202017081720(2020.2002.2006.20020974) 12AlexanderL.SmallJ.EdwardsS.BaricR.An experimental model for dilated cardiomyopathy after"/>
  <result pre="2019 novel coronavirus diseases (COVID-19) - ChinaChina CDC Weekly222020113122 20MusherD.AbersM.Corrales-MedinaV.Acute" exact="infection" post="and myocardial infarctionN. Engl. J. Med.380201917117630625066 21S. G, Shanghai"/>
  <result pre="death of the first patient with novel coronavirus pneumonia is" exact="infection" post="in Shanghaihttp://shpeoplecomcn/n2/2020/0126/c134768-33745589html2020 22RongY.LiuY.MaX.ChangB.YangY.Damage to non-pulmonary organs like heart and"/>
  <result pre="patients with COVID-19 treated with hydroxychloroquine and azithromycinNat. Med.222020808809 44ZJ.The" exact="treatment" post="and explanation of novel coronavirus pneumonia infection from Xiehe"/>
  <result pre="azithromycinNat. Med.222020808809 44ZJ.The treatment and explanation of novel coronavirus pneumonia" exact="infection" post="from Xiehe hospital in Wuhanhttps://wwwdxycn/bbs/newweb/pc/post/426622542020 45TeragawaH.HondoT.AmanoH.HinoF.OhbayashiM.Adverse effects of interferon"/>
  <result pre="Triple combination of interferon beta-1b, lopinavirâ€&quot;ritonavir, and ribavirin in the" exact="treatment" post="of patients admitted to hospital with COVID-19: an open-label,"/>
  <result pre="vitroCell Res.30202026927132020029 55GaoJ.TianZ.YangX.Breakthrough: chloroquine phosphate has shown apparent efficacy in" exact="treatment" post="of COVID-19 associated pneumonia in clinical studiesBioscience trends142020727332074550 56HoffmannM.Kleine-WeberH.SchroederS.KrugerN.HerrlerT.ErichsenS.SARS-CoV-2"/>
  <result pre="Novel Wuhan Coronavirus (COVID-19 )2020American College of Cardiology 76LiR.PeiS.ChenB.SongY.ZhangT.YangW.Substantial undocumented" exact="infection" post="facilitates the rapid dissemination of novel coronavirus (SARS-CoV2)Science (New"/>
 </snippets>
</snippetsTree>
